Table 2. Analysis of p540 tetramer... | American Society of Hematology

Table 2.

Analysis of p540⁺ tetramer binding to circulating CD8⁺ T cells in HLA-A2⁺ cancer patients

Patient no.	Tetramer-positive CD8⁺ T cells, %	PSA, ng/mL
1	0.36	12.7
2	0.32	20.8
3	0.4	7.5
6	1.4	0
7	0	6.1
8	0.19	7
9	0.28	5.6
11	0.4	35
12	0.11	21
13	0.7	9.7
14	0.7	16
15	0.35	4.9
17	0.4	10
18	0.4	18
19	0.18	—
20	0.22	—
21	0	—
23	0.25	—
24	0.36	—
25	0.31	—
26	0.1	—
27	0.37	—

Patient no.	Tetramer-positive CD8⁺ T cells, %	PSA, ng/mL
1	0.36	12.7
2	0.32	20.8
3	0.4	7.5
6	1.4	0
7	0	6.1
8	0.19	7
9	0.28	5.6
11	0.4	35
12	0.11	21
13	0.7	9.7
14	0.7	16
15	0.35	4.9
17	0.4	10
18	0.4	18
19	0.18	—
20	0.22	—
21	0	—
23	0.25	—
24	0.36	—
25	0.31	—
26	0.1	—
27	0.37	—

— indicates patients not affected with prostate cancer.